High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial

References

• Genazzani AD. Inositol as a putative integrative treatment for PCOS. Reprod Biomed Online. 2016;33(6):770–780.
   PubMed Web of Science ®Google Scholar
• Mendoza N, Pérez L, Simoncini T, et al. Inositol supplementation in women with polycystic ovary syndrome undergoing intracytoplasmic sperm injection: a systematic review and meta-analysis of randomized controlled trials. Reprod Biomed Online. 2017;35(5):529–535.
   PubMed Web of Science ®Google Scholar
• Bevilacqua A, Dragotto J, Giuliani A, et al. Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model. J Cell Physiol. 2019;234(6):9387–9398.
   PubMed Web of Science ®Google Scholar
• Mendoza N, Diaz-Ropero MP, Aragon M. Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial. Gynecol Endocrinol. 2019;35(8):695–700.
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
   Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. Vienna (Austria): R Foundation for Statistical Computing; 2018. Available from: https://www.R-project.org/
   Google Scholar
• Fox J, Weisberg S. 2011. An R companion to applied regression. 2nd ed. Thousand Oaks (CA): Sage. Available from: http://socserv.socsci.mcmaster.ca/jfox/Books/Companion
   Google Scholar
• Bates D, Mächler M, Bolker B, et al. Fitting linear mixed-effects models using lme4. J Stat Soft. 2015;67(1):1–48.
   Web of Science ®Google Scholar
• Barton K. 2018. MuMIn: Multi-Model Inference. R package version 1.42.1. Available from: https://CRAN.R-project.org/package=MuMIn
   Google Scholar
• Facchinetti F, Orrù B, Grandi G, et al. Short-term effects of metformin and myo-inositol in women with the polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials. Gynecol Endocrinol. 2019;35(3):198–206.
   PubMed Web of Science ®Google Scholar
• Piomboni P, Focarelli R, Capaldo A, et al. Protein modification as an oxidative stress marker in follicular fluid from women with polycystic ovary syndrome: the effect of inositol and metformin. J Assist Reprod Genet. 2014;31(10):1269–1276.
   PubMed Web of Science ®Google Scholar
• Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology. The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod. 2011;26:1270–1283. Reprod Biomed Online. 2011;22:632–646.
   PubMed Web of Science ®Google Scholar
• Sortino MA, Salomone S, Carruba MO, et al. Polycystic ovary syndrome: insights into the therapeutic approach with inositols. Front Pharmacol. 2017;8:341.
   PubMed Web of Science ®Google Scholar
• Rienzi L, Vajta G, Ubaldi F. Predictive value of oocyte morphology in human IVF: a systematic review of the literature. Hum Reprod Update. 2011;17(1):34–45.
   PubMed Web of Science ®Google Scholar
• Goud PT, Goud AP, Joshi N, et al. Dynamics of nitric oxide, altered follicular microenvironment, and oocyte quality in women with endometriosis. Fertil Steril. 2014;102(1):151–159.
   PubMed Web of Science ®Google Scholar
• Albertini DF, Sanfins A, Combelles CM. Origins and manifestations of oocyte maturation competencies. Reprod Biomed Online. 2003;6(4):410–415.
   PubMedGoogle Scholar
• Eini F, Novin MG, Joharchi K, et al. Intracytoplasmic oxidative stress reverses epigenetic modifications in polycystic ovary syndrome. Reprod Fertil Dev. 2017;29(12):2313–2323.
   PubMed Web of Science ®Google Scholar
• Bausenwein J, Serke H, Eberle K, et al. Elevated levels of oxidized low-density lipoprotein and of catalase activity in follicular fluid of obese women. Mol Hum Reprod. 2010;16(2):117–124.
   PubMed Web of Science ®Google Scholar
• Chattopadhayay R, Ganesh A, Samanta J, et al. Effect of follicular fluid oxidative stress on meiotic spindle formation in infertile women with polycystic ovarian syndrome. Gynecol Obstet Invest. 2010;69(3):197–202.
   PubMed Web of Science ®Google Scholar
• Nestler JE, Jakubowicz DJ, Reamer P, et al. Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome. N Engl J Med. 1999;340(17):1314–1320.
   PubMed Web of Science ®Google Scholar
• Morgante G, Orvieto R, Di Sabatino A, et al. The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. Fertil Steril. 2011;95(8):2642–2644.
   PubMed Web of Science ®Google Scholar
• Zheng W, Nagaraju G, Liu Z, et al. The functional roles of the phosphatidylinositol 3-kinases (PI3Ks) signaling in the mammalian ovary. Mol Cell Endocrinol. . 2012;356(1–2):24–30.
   PubMed Web of Science ®Google Scholar
• Zheng W, Gorre N, Shen Y, et al. Maternal phosphatidylinositol 3-kinase signaling is crucial for embryonic genome activation and preimplantation embryogenesis. EMBO Rep. 2010;11(11):890–895.
   PubMed Web of Science ®Google Scholar
• Zheng W, Liu K. The emerging role of maternal phosphatidylinositol 3 kinase (PI3K) signaling in manipulating mammalian preimplantation embryogenesis. Cell Cycle. 2011;10(2):178–179.
   PubMed Web of Science ®Google Scholar